62 related articles for article (PubMed ID: 28087261)
1. DNA aptamer probes for detection of estrogen receptor α positive carcinomas.
Sett A; Borthakur BB; Sharma JD; Kataki AC; Bora U
Transl Res; 2017 May; 183():104-120.e2. PubMed ID: 28087261
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer.
Ahirwar R; Vellarikkal SK; Sett A; Sivasubbu S; Scaria V; Bora U; Borthakur BB; Kataki AC; Sharma JD; Nahar P
PLoS One; 2016; 11(4):e0153001. PubMed ID: 27043307
[TBL] [Abstract][Full Text] [Related]
3. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract][Full Text] [Related]
4. In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules.
Ahirwar R; Nahar S; Aggarwal S; Ramachandran S; Maiti S; Nahar P
Sci Rep; 2016 Feb; 6():21285. PubMed ID: 26899418
[TBL] [Abstract][Full Text] [Related]
5. An aptasensor for rapid and sensitive detection of estrogen receptor alpha in human breast cancer.
Ahirwar R; Dalal A; Sharma JG; Yadav BK; Nahar P; Kumar A; Kumar S
Biotechnol Bioeng; 2019 Jan; 116(1):227-233. PubMed ID: 30132794
[TBL] [Abstract][Full Text] [Related]
6. In search of novel drug target sites on estrogen receptors using RNA aptamers.
Xu D; Chatakonda VK; Kourtidis A; Conklin DS; Shi H
Nucleic Acid Ther; 2014 Jun; 24(3):226-38. PubMed ID: 24588102
[TBL] [Abstract][Full Text] [Related]
7. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
8. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
9. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
10. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
[TBL] [Abstract][Full Text] [Related]
11. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer.
Zhao Y; Deng C; Wang J; Xiao J; Gatalica Z; Recker RR; Xiao GG
Breast Cancer Res Treat; 2011 May; 127(1):69-80. PubMed ID: 20535543
[TBL] [Abstract][Full Text] [Related]
12. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
13. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
[TBL] [Abstract][Full Text] [Related]
14. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
15. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
18. [The Application of Estrogen Receptor Aptamer in Immunohistochemical Detection of Breast Cancer].
He X; Chen J; Ye SM; Dong DD; Li K; Zhou TY; Zhao LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):385-389. PubMed ID: 31631608
[TBL] [Abstract][Full Text] [Related]
19. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.
Fox SB; Brown P; Han C; Ashe S; Leek RD; Harris AL; Banham AH
Clin Cancer Res; 2004 May; 10(10):3521-7. PubMed ID: 15161711
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
